4l0l
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | ==Crystal structure of P.aeruginosa PBP3 in complex with compound 4== | |
| - | + | <StructureSection load='4l0l' size='340' side='right' caption='[[4l0l]], [[Resolution|resolution]] 2.10Å' scene=''> | |
| - | + | == Structural highlights == | |
| + | <table><tr><td colspan='2'>[[4l0l]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/"bacillus_aeruginosus"_(schroeter_1872)_trevisan_1885 "bacillus aeruginosus" (schroeter 1872) trevisan 1885]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L0L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4L0L FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=PFV:(6R,7S,10Z)-10-(2-AMINO-1,3-THIAZOL-4-YL)-1-(1,5-DIHYDROXY-4-OXO-1,4-DIHYDROPYRIDIN-2-YL)-7-FORMYL-13,13-DIMETHYL-3,9-DIOXO-6-(SULFOAMINO)-12-OXA-2,4,8,11-TETRAAZATETRADEC-10-EN-14-OIC+ACID'>PFV</scene></td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">pbpB ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=287 "Bacillus aeruginosus" (Schroeter 1872) Trevisan 1885])</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4l0l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4l0l OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4l0l RCSB], [http://www.ebi.ac.uk/pdbsum/4l0l PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Herein we describe the structure-aided design and synthesis of a series of pyridone-conjugated monobactam analogues with in vitro antibacterial activity against clinically relevant Gram-negative species including Pseudomonas aeruginosa , Klebsiella pneumoniae , and Escherichia coli . Rat pharmacokinetic studies with compound 17 demonstrate low clearance and low plasma protein binding. In addition, evidence is provided for a number of analogues suggesting that the siderophore receptors PiuA and PirA play a role in drug uptake in P. aeruginosa strain PAO1. | ||
| - | + | Pyridone-Conjugated Monobactam Antibiotics with Gram-Negative Activity.,Brown MF, Mitton-Fry MJ, Arcari JT, Barham R, Casavant J, Gerstenberger BS, Han S, Hardink JR, Harris TM, Hoang T, Huband MD, Lall MS, Lemmon MM, Li C, Lin J, McCurdy SP, McElroy E, McPherson C, Marr ES, Mueller JP, Mullins L, Nikitenko AA, Noe MC, Penzien J, Plummer MS, Schuff BP, Shanmugasundaram V, Starr JT, Sun J, Tomaras A, Young JA, Zaniewski RP J Med Chem. 2013 Jun 27. PMID:23755848<ref>PMID:23755848</ref> | |
| - | + | ||
| - | == | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
| - | + | </div> | |
| - | [[Category: Han, S | + | |
| - | [[Category: Marr, E S | + | ==See Also== |
| + | *[[Penicillin-binding protein|Penicillin-binding protein]] | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Han, S]] | ||
| + | [[Category: Marr, E S]] | ||
[[Category: Penicillin binding protein 3]] | [[Category: Penicillin binding protein 3]] | ||
[[Category: Penicillin binding protein-antibiotic complex]] | [[Category: Penicillin binding protein-antibiotic complex]] | ||
Revision as of 17:15, 21 December 2014
Crystal structure of P.aeruginosa PBP3 in complex with compound 4
| |||||||||||
